Ardelyx reported $105.66M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Amgen USD 5.13B 1.39B Sep/2025
Ardelyx USD 105.66M 6.4M Sep/2025
aTyr Pharma USD 26.94M 6.63M Sep/2025
Corcept Therapeutics USD 197.42M 29.66M Sep/2025
Sanofi EUR 10.71B 1.32B Dec/2025
TG Therapeutics USD 132.34M 26.04M Sep/2025
United Therapeutics USD 6.59B 6.07B Sep/2025